VIRIDIAN THERAPEUTICS INC. - COMMON STOCK
20.08
30-1月-25 15:45:00
15 分の遅延
株式
+0.65
+3.35%
本日の幅
19.39 - 20.42
ISIN
N/A
ソース
NASDAQ
-
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
11 8 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference
05 8 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer
26 7 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
15 7 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14 7 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference
07 7 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference
10 6 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Viridian Therapeutics to Participate in Upcoming Investor Conferences
14 5 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
06 5 2021 15:05:01 提供 Nasdaq GlobeNewswire
-
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
25 3 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
09 3 2021 15:30:00 提供 Nasdaq GlobeNewswire